TMDX Oct 2024 90.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:20AM EDT. Market open.
| Previous Close | 43.50 |
| Open | 14.50 |
| Bid | 50.00 |
| Ask | 54.00 |
| Strike | 90.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 14.50 - 43.50 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 11 |
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 14, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 18,320 shares of its common stock and an aggregate of 12,068 restricted stock units to 8 employees, each as a material inducement for each employee's entry into employment with TransMedics. The g
ZacksAre You Looking for a Top Momentum Pick? Why TransMedics (TMDX) is a Great Choice
Does TransMedics (TMDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
GuruFocus.comInsider Sale: Director Edward Basile Sells Shares of TransMedics Group Inc (TMDX)
On May 7, 2024, Edward Basile, Director at TransMedics Group Inc (NASDAQ:TMDX), sold 7,157 shares of the company.
© 2024 Yahoo. All rights reserved.